Richland, WA, United States of America

Xingye Cherry Lei

USPTO Granted Patents = 3 


Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2002-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Xingye Cherry Lei

Introduction

Xingye Cherry Lei, based in Richland, WA, is an accomplished inventor with a focus on advancements in radiotherapy and diagnostics. With three patents to his name, Lei is making significant contributions to the field of medical technology, particularly in cancer treatment.

Latest Patents

Xingye Cherry Lei's latest patents are dedicated to the innovation of particulate materials for radiotherapy. One notable invention involves timed-bioresorbable particulates, specifically designed as microspheres or fibers. These particulates serve as a vehicle for the delivery of radioisotopes like Y-90 and Pd-103, which are crucial for localized radiotherapy or act as embolic devices. Furthermore, these innovative particulates can be embedded in polymers or dispersed in injectable gels, enhancing cancer treatment methods. The patents also highlight the benefit of bioresorption and the ability to control the ratio of radioisotopes in the particulates, specifically focusing on gamma and beta ratios, such as the In-111/Y-90 ratio. Additionally, the patents emphasize the advantages of using non-conductive implants.

Career Highlights

Throughout his career, Xingye Cherry Lei has played a pivotal role in developing cutting-edge medical technologies. He has worked with companies such as Xl Sci-Tech, Inc. and Biofield Corporation, where his expertise in innovative materials and techniques has led to the advancement of therapeutic products aimed at improving patient outcomes in cancer treatment.

Collaborations

Lei's contributions extend beyond individual inventions, as he has collaborated with other skilled professionals in the field. Notable coworkers include Yongren Benjamin Peng and Jack A. Cuzick, with whom he has shared ideas and insights that propel the development of new solutions in radiotherapy and diagnostics.

Conclusion

Xingye Cherry Lei exemplifies the spirit of innovation in the medical field. His work on particulate materials for radiotherapy highlights the importance of creativity and collaboration in advancing healthcare technologies. As he continues to develop new inventions, Lei is sure to leave a lasting impact on cancer treatment and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…